Is Endovascular Arteriovenous Fistula a Feasible Alternative for Hemodialysis Patients?
Blood Purification · 2024
DOI: 10.1159/000541233 ↗Kurz gefasst
Fachartikel in der Zeitschrift Blood Purification, 2024. Verfasst von Hugo Vergara-Pérez und 7 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology Department, Hospital General Universitario de Castellón, Castellón de la Plana, Spain. Hauptthemen laut MEDLINE: Renal Dialysis, Arteriovenous Shunt, Surgical, Endovascular Procedures. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben.
Abstract (Originalsprache)
Introduction
For hemodialysis (HD) patients, the selection of vascular access is a crucial factor that significantly affects morbidity and mortality. Historically, native arteriovenous fistulas (AVFs) have been established using surgical techniques. However, devices facilitating percutaneous endovascular arteriovenous fistula (endoAVF) formation have recently been introduced in clinical practice, showing promising initial evidence. The primary objectives were technical success, efficacy, and cannulation rates. The secondary objectives included primary and cumulative patency, safety, and the number of procedures required to maintain fistula patency.
Methods
A prospective, single-center, single-arm study included all patients who underwent endoAVF creation using the WavelinQ™ EndoAVF System at a University Hospital between December 2021 and August 2023.
Results
A total of 20 patients who underwent an endoAVF were included. Technical success was 100%. In total, 75% (15) of the endoAVFs met the criteria for physiological suitability. The cannulation rate was 66% (10/15) for endoAVFs that reached physiological suitability. At 6 months of follow-up, the primary and cumulative patency rates were 65% and 75%, respectively; at 12 months, these were 50% and 70%, respectively. Serious adverse events were not observed. The reintervention rate was 0.33 procedures/patient-year.
Conclusion
Based on our experience, creating AVFs using the WavelinQ 4-F EndoAVF System is safe and effective, with high technical success rates and acceptable patency and reintervention rates.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Nephrology Department, Hospital General Universitario de Castellón, Castellón de la Plana, Spain.
- Radiology Department, Hospital General Universitario de Castellón, Castellón de la Plana, Spain.
- Department of Health Sciences, Universidad Jaume I, Castellón de la Plana, Spain.
Zitieren
APA
Vergara-Pérez, H., Diaitz-Usetxi Laplaza, R., Pérez Alba, A., Baliño Remiro, P., Rius Peris, A., Fenollosa Segarra, M. Á., Tamayo Vasquez, A., & Reque, J. (2024). Is Endovascular Arteriovenous Fistula a Feasible Alternative for Hemodialysis Patients?. Blood Purification. https://doi.org/10.1159/000541233
Vancouver
Vergara-Pérez H, Diaitz-Usetxi Laplaza R, Pérez Alba A, Baliño Remiro P, Rius Peris A, Fenollosa Segarra MÁ, et al. Is Endovascular Arteriovenous Fistula a Feasible Alternative for Hemodialysis Patients?. Blood Purification. 2024. doi:10.1159/000541233
BibTeX
@article{VergaraPrez2024,
author = {Vergara-Pérez, Hugo and Diaitz-Usetxi Laplaza, Raúl and Pérez Alba, Alejandro and Baliño Remiro, Pablo and Rius Peris, Asunción and Fenollosa Segarra, M Ángeles and Tamayo Vasquez, Alejandro and Reque, Javier},
title = {Is Endovascular Arteriovenous Fistula a Feasible Alternative for Hemodialysis Patients?},
journal = {Blood Purification},
year = {2024},
doi = {10.1159/000541233}
}
EUVIMED